Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Pharma
BMS details Krazati confirmatory fail in colorectal cancer
BMS has detailed a phase 3 flop for KRAS inhibitor Krazati's smaller-opportunity accelerated FDA approval in colorectal cancer.
Fraiser Kansteiner
Jul 7, 2026 10:46am
Astellas, Takeda, RA Capital—Fierce Pharma Asia
Jun 12, 2026 8:23am
Fierce Biotech
Takeda’s TYK2 inhibitor beats BMS’ Sotyktu in psoriasis showdown
Jun 11, 2026 7:00am
BMS taps ‘SVU’ detective to investigate myeloma in new campaign
Jun 8, 2026 1:17pm
At ASCO, China biotech industry cements its coming of age
Jun 3, 2026 8:50am
J&J dismisses 56 from HQ as part of orthopedics separation
May 27, 2026 11:14am
